Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. [electronic resource]
Producer: 20201117Description: 383-391 p. digitalISSN:- 1432-1041
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.